Questions: Kinetics of Adaptive Immune Response and Response Phases

Question 1

A patient presents with acute respiratory illness. Serology shows high IgM titers against a specific respiratory virus but no detectable IgG. What is the most likely interpretation?

• A. The patient has had prior exposure to this virus and is experiencing a reactivation; IgM is produced first in secondary responses
• B. This is most likely a primary infection — IgM appears before class switching occurs, so high IgM with absent IgG indicates an early-stage primary response
• C. The patient's immune system has failed to produce class-switched antibodies, suggesting immunodeficiency
• D. The IgG test was probably performed incorrectly and should be repeated

Answer: (B)

IgM is the default antibody isotype produced during the lag and early expansion phases of a primary response, before germinal center reactions drive class switch recombination to IgG. In a secondary response, memory B cells that have already undergone class switching produce IgG rapidly — IgM is largely absent. Therefore, high IgM with no IgG is the serological signature of an acute primary infection, while IgG alone (or IgG with a low IgM) suggests prior exposure or vaccination. This IgM → IgG transition is the basis of clinical serology for distinguishing acute from past infection.

Question 2

A vaccine manufacturer is designing a two-dose schedule for a protein subunit vaccine. Why is the timing interval between doses critical for maximizing the secondary immune response?

• A. The second dose must be given while the primary response is still at peak titer to 'stack' antibody levels
• B. Boosting too early — before memory cells have differentiated and the primary response has contracted — produces a weaker secondary response than boosting after sufficient time has elapsed
• C. The interval only matters for live attenuated vaccines; for protein subunits, the second dose should be given as soon as possible
• D. The interval determines which isotype is produced; shorter intervals favor IgM, longer intervals favor IgG

Answer: (B)

After the primary response peaks around days 10-14, the majority of effector cells undergo apoptosis in the contraction phase, and a small pool of long-lived memory B and T cells differentiates and persists. The secondary response depends on these memory cells — if you boost before memory cells have fully differentiated (i.e., during the contraction phase), you may re-stimulate remaining effector cells rather than true memory cells, producing a weaker response. Standard vaccine schedules (e.g., weeks to months between doses) are designed to allow complete development of immunological memory before boosting, maximizing the qualitative advantages of the secondary response.

Question 3

In a secondary immune response, antibodies are predominantly IgG rather than IgM because memory B cells have already undergone class switch recombination during the primary response.

• T. True
• F. False

Answer: True

During the primary response, germinal center reactions drive somatic hypermutation and class switch recombination. Memory B cells that exit the germinal center have already switched from IgM to IgG (or other isotypes) and carry this epigenetic change with them. When these cells are reactivated during a secondary response, they produce the isotype they already express — predominantly IgG — without needing to undergo class switching again. This accounts for the rapid appearance of high-titer IgG in secondary responses and the relative absence of IgM.

Question 4

The secondary immune response is simply a faster and stronger version of the primary response, using the same naive lymphocyte activation process but with more of those cells available.

• T. True
• F. False

Answer: False

This is the key misconception identified in this topic. The secondary response is qualitatively different, not just quantitatively faster. Memory B cells have undergone somatic hypermutation and affinity maturation, so the antibodies they produce have higher affinity for the antigen — this is not simply speed but improved binding. Memory T cells require less co-stimulation to activate and respond more vigorously. The antibody isotype is different (predominantly IgG, not IgM). These qualitative differences — higher affinity, faster kinetics, different isotype, lower activation threshold — are why the secondary response is so effective at preventing symptomatic disease, not merely because there are more starting cells.

Question 5

Why do individuals typically experience no symptoms during a second exposure to a pathogen that caused significant illness during the first exposure?

Model answer: During the primary response, the immune system generates long-lived memory B and T cells. On re-exposure, these memory cells respond within 1-3 days — far faster than the 5-7 day lag of the primary response — and produce antibody titers 10-100 fold higher, of higher affinity, and predominantly as class-switched IgG. This rapid, high-affinity response neutralizes the pathogen and clears infected cells before it can replicate to disease-causing levels. The pathogen is eliminated by the immune response faster than it can establish infection, so there is no symptomatic illness. This is the mechanistic basis of protective immunity and the goal of vaccination.

The speed advantage of the secondary response is critical: symptoms of infection arise when pathogen levels reach a threshold; the secondary response clears the pathogen below that threshold before it is reached. Vaccines exploit this by inducing a primary response (and therefore memory) without disease, so that the first encounter with the actual pathogen elicits a secondary response. The qualitative improvements in affinity and isotype also matter — high-affinity IgG is more effective at neutralization and opsonization than the lower-affinity IgM produced early in a primary response.